Citation Impact
Citing Papers
Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study
2017 Standout
Identification of a Primary Target of Thalidomide Teratogenicity
2010 StandoutScience
Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma
2012 Standout
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Modified DNA Aptamer That Binds the ( R )-Isomer of a Thalidomide Derivative with High Enantioselectivity
2007
Salvage therapy for refractory chronic graft-versus-host disease with mycophenolate mofetil and tacrolimus
1999
Mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant patients
1998
Hydroxychloroquine for the treatment of chronic graft-versus-host disease
2000
IL-7 enhances peripheral T cell reconstitution after allogeneic hematopoietic stem cell transplantation
2003
Cutaneous Graft-versus-Host Disease
1998
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
Chronic graft-versus-host disease: clinical manifestation and therapy
2001
Consensus Conference on Clinical Practice in Chronic GVHD: Second-Line Treatment of Chronic Graft-versus-Host Disease
2010
Infections in adults undergoing unrelated donor bone marrow transplantation
1999
The role of thalidomide in the treatment of refractory chronic graft-versus-host disease following bone marrow transplantation in children
1998
Autologous bone marrow transplantation in non-Hodgkin's lymphoma: monoclonal antibodies plus complement for ex Vivo marrow treatment
1988
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Mesenchymal Stem Cell-Mediated Immunosuppression Occurs via Concerted Action of Chemokines and Nitric Oxide
2008 Standout
Response to thalidomide therapy in refractory chronic graft-versus-host disease
2000
Transplantation-associated thrombotic microangiopathy after steroid pulse therapy for polyserositis related to graft-versus-host disease
2010 StandoutNobel
Vascular disorders of the liver # †
2008 Standout
A structure-based computational workflow to predict liability and binding modes of small molecules to hERG
2020 StandoutNobel
Chronic graft-versus-host disease
2003 Standout
Outcomes among 562 Recipients of Placental-Blood Transplants from Unrelated Donors
1998 Standout
Inflammatory Bowel Disease
2002 Standout
Graft-versus-host disease
2009 Standout
PATHOPHYSIOLOGY AND TREATMENT OF GRAFT-VERSUS-HOST DISEASE
1999
Different efficacy of mycophenolate mofetil as salvage treatment for acute and chronic GVHD after allogeneic stem cell transplant
2004
B-Cell Monoclonal Antibodies and Their Use in Clinical Oncology
1991
Circos: An information aesthetic for comparative genomics
2009 Standout
Chemotherapy Compared with Autologous or Allogeneic Bone Marrow Transplantation in the Management of Acute Myeloid Leukemia in First Remission
1998
Changing from cyclosporine to tacrolimus as salvage therapy for chronic graft-versus-host disease
2000
Long-Term Results of Autologous Stem Cell Transplantation for Primary Refractory or Relapsed Hodgkin’s Lymphoma
2006
Aspergillosis Case-Fatality Rate: Systematic Review of the Literature
2001 Standout
IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma.
1997 Standout
Oral Graft-Versus-Host Disease
2008
An open-label pilot study of low-dose thalidomide in chronically active, steroid-dependent Crohn's disease
1999
Intensified induction chemotherapy in adult acute myeloid leukemia followed by high-dose chemotherapy and autologous peripheral blood stem cell transplantation: an eastern cooperative oncology group trial (E4995)
2004
Outcomes of transplantation with matched-sibling and unrelateddonor bone marrow in children with leukaemia
1997
The management and outcome of chronic graft‐versus‐host disease
2007
The Japanese multicenter open randomized trial of ursodeoxycholic acid prophylaxis for hepatic veno-occlusive disease after stem cell transplantation
2000
A review of autologous hematopoietic cell transplantation
2000 Nobel
Randomized clinical trial of thalidomide, cyclosporine, and prednisone versus cyclosporine and prednisone as initial therapy for chronic graft-versus-host disease
2001
A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation
2001
The thalidomide saga
2007
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Salvage therapy with thalidomide in multiple myeloma patients relapsing after autologous peripheral blood stem cell transplantation.
2001
Functional Nucleic Acid Sensors
2009 Standout
IL-7 enhances peripheral T cell reconstitution after allogeneic hematopoietic stem cell transplantation
2003
The rise, fall and subsequent triumph of thalidomide: lessons learned in drug development
2011
Autologous stem cell transplantation for HIV-associated lymphoma
2001
Improved survival in multiple myeloma and the impact of novel therapies
2007 Standout
Autologous Stem Cell Transplantation in Acute Myelocytic Leukemia
1998
High dose therapy and autologous stem cell transplantation for human immunodeficiency virus-associated non-Hodgkin lymphoma in the era of highly active antiretroviral therapy
2000
Autologous Stem Cell Transplantation in Acute Myelocytic Leukemia
1998
Bone Marrow Transplant
1990 Standout
Treatment of Primary Progressive Hodgkin’s and Aggressive Non-Hodgkin’s Lymphoma: Is There a Chance for Cure?
2000
Guidelines for Preventing Health-Care-Associated Pneumonia, 2003: Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee
2004 Standout
Thalidomide for treatment of patients with chronic graft-versus-host disease
2000
GITR Activation Induces an Opposite Effect on Alloreactive CD4+ and CD8+ T Cells in Graft-Versus-Host Disease
2004 StandoutNobel
PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
2014 Standout
World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting—Airlie House, Virginia, November 1997
1999 Standout
Novel therapeutics for the treatment of graft-versus-host disease
2002
Hodgkin's lymphoma
2003
Treatment of Chronic Graft-Versus-Host Disease With Clofazimine
1997
Comparison of Autologous and Allogeneic Bone Marrow Transplantation for Treatment of High-Risk Refractory Acute Lymphoblastic Leukemia
1987
Works of DE Stepan being referenced
In vivo purging with high-dose cytarabine followed by high-dose chemoradiotherapy and reinfusion of unpurged bone marrow for adult acute myelogenous leukemia in first complete remission.
1996
Utilization of a colony assay to assess the variables influencing elimination of leukemic cells from human bone marrow with monoclonal antibodies and complement
1985
The outcome of matched unrelated donor bone marrow transplantation in patients with hematologic malignancies using molecular typing for donor selection and graft-versus-host disease prophylaxis regimen of cyclosporine, methotrexate, and prednisone
1995
Thalidomide as salvage therapy for chronic graft-versus-host disease
1995
High-dose chemotherapy with or without total body irradiation followed by autologous bone marrow and/or peripheral blood stem cell transplantation for patients with relapsed and refractory Hodgkin's disease: results in 85 patients with analysis of prognostic factors
1995